1. Home
  2. CADL

as 06-21-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Founded: 1999 Country:
United States
United States
Employees: N/A City: NEEDHAM
Market Cap: 232.0M IPO Year: 2021
Target Price: $11.00 AVG Volume (30 days): 869.2K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.28 EPS Growth: N/A
52 Week Low/High: $0.66 - $14.30 Next Earning Date: 08-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

CADL Daily Stock ML Predictions

Share on Social Networks: